These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 15307110

  • 21. Reversible posterior leukoencephalopathy syndrome induced by vinorelbine.
    Chen YH, Huang CH.
    Clin Breast Cancer; 2012 Jun; 12(3):222-5. PubMed ID: 22424944
    [Abstract] [Full Text] [Related]

  • 22. Linezolid-induced posterior reversible leukoencephalopathy syndrome.
    Nagel S, Köhrmann M, Huttner HB, Storch-Hagenlocher B, Schwab S.
    Arch Neurol; 2007 May; 64(5):746-8. PubMed ID: 17502475
    [Abstract] [Full Text] [Related]

  • 23. [Posterior reversible leukoencephalopathy syndrome caused by cisplatin: a case report].
    Romano LM, de Robles P, Ioli P, García-Saiz E.
    Rev Neurol; 2007 May; 41(9):573-4. PubMed ID: 16254865
    [No Abstract] [Full Text] [Related]

  • 24. Spectrum and potential pathogenesis of reversible posterior leukoencephalopathy syndrome.
    Li Y, Gor D, Walicki D, Jenny D, Jones D, Barbour P, Castaldo J.
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):873-82. PubMed ID: 21703874
    [Abstract] [Full Text] [Related]

  • 25. [Reversible posterior leukoencephalopathy or brain tumor--case report].
    Ribarić B, Milat D, Gadze ZP, Franjić J, Petravić D.
    Lijec Vjesn; 2010 Nov; 132(5-6):151-4. PubMed ID: 20677621
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed.
    Stott VL, Hurrell MA, Anderson TJ.
    Intern Med J; 2005 Feb; 35(2):83-90. PubMed ID: 15705136
    [Abstract] [Full Text] [Related]

  • 28. Reversible posterior leukoencephalopathy induced by cancer chemotherapy.
    Baytan B, Ozdemir O, Demirkaya M, Evim MS, Gunes AM.
    Pediatr Neurol; 2010 Sep; 43(3):197-201. PubMed ID: 20691942
    [Abstract] [Full Text] [Related]

  • 29. Posterior reversible encephalopathy syndrome.
    Pula JH, Eggenberger E.
    Curr Opin Ophthalmol; 2008 Nov; 19(6):479-84. PubMed ID: 18854692
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of nine children with reversible posterior encephalopathy syndrome.
    Incecik F, Hergüner MO, Altunbasak S, Erbey F, Leblebisatan G.
    Neurol India; 2009 Nov; 57(4):475-8. PubMed ID: 19770551
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Posterior reversible encephalopathy syndrome: 5 chemotherapy related cases].
    San Martín García I, Urabayen Alberdi R, Díez Bayona V, Sagaseta de Ilúrdoz Uranga M, Esparza Estaun J, Molina Garicano J, Berisa Prado S.
    An Pediatr (Barc); 2014 Feb; 80(2):117-21. PubMed ID: 23786801
    [Abstract] [Full Text] [Related]

  • 33. Neuroimaging in posterior reversible encephalopathy syndrome.
    Lamy C, Oppenheim C, Méder JF, Mas JL.
    J Neuroimaging; 2004 Apr; 14(2):89-96. PubMed ID: 15095552
    [Abstract] [Full Text] [Related]

  • 34. Reversible posterior leukoencephalopathy syndrome: report of 2 simultaneous cases in children.
    D'Angelo P, Farruggia P, Lo Bello A, Trizzino A, Tropia S, Caselli D, Aricò M.
    J Pediatr Hematol Oncol; 2006 Mar; 28(3):177-81. PubMed ID: 16679945
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Neuropsychiatric lupus and reversible posterior leucoencephalopathy syndrome: a challenging clinical dilemma.
    Mak A, Chan BP, Yeh IB, Ho RC, Boey ML, Feng PH, Koh DR, Ong BK.
    Rheumatology (Oxford); 2008 Mar; 47(3):256-62. PubMed ID: 18084001
    [Abstract] [Full Text] [Related]

  • 37. Reversible posterior leukoencephalopathy syndrome.
    Moon JM, Chun BJ.
    J Emerg Med; 2010 Apr; 38(3):e1-4. PubMed ID: 18024064
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Reversible posterior leukoencephalopathy syndrome after repeat intermediate-dose cytarabine chemotherapy in a patient with acute myeloid leukemia.
    Saito B, Nakamaki T, Nakashima H, Usui T, Hattori N, Kawakami K, Tomoyasu S.
    Am J Hematol; 2007 Apr; 82(4):304-6. PubMed ID: 16947320
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.